Try our Advanced Search for more refined results
Searching dockets in Northwest Biotherapeutics Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Securities/Commodities | New York Southern
Response in Opposition to Motion
LETTER RESPONSE in Opposition to Motion addressed to Magistrate Judge Gary Stein from Stephen W. Tountas dated August 6, 2026 re: 311 LETTER MOTION for Leave to File Reply in Support of Defendants' Request for a Pre-Motion Conference Regarding Defendants' Anticipated Motion for Clarification or Reconsideration of the Court's July 10, 2026, Order ECF 299 a . Document filed by Northwest Biotherapeutics, Inc...(Tountas, Stephen)
Leave to File Document
***SEALED*** LETTER MOTION for Leave to File Reply in Support of Defendants' Request for a Pre-Motion Conference Regarding Defendants' Anticipated Motion for Clarification or Reconsideration of the Court's July 10, 2026, Order ECF 299 addressed to Magistrate Judge Gary Stein from Peter H. Fountain dated August 3, 2026. Document filed by Citadel Securities LLC, G1 Execution Services LLC, GTS Securities LLC, Instinet LLC, Lime Trading Corp., Virtu Americas LLC. (Attachments: # 1 Exhibit A - Proposed Reply)Motion or Order to File Under Seal: 309 .(Fountain, Peter)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.